Glucose alters the evolutionary response to gentamicin in uropathogenic Escherichia coli
Microbiology · 2025
DOI: 10.1099/mic.0.001548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology, 2025. Verfasst von Shalini Choudhary und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Bi…. Hauptthemen laut MEDLINE: Uropathogenic Escherichia coli, Glucose, Gentamicins, Anti-Bacterial Agents. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Urinary tract infections (UTI) are a major health and economic concern. Uropathogenic Escherichia coli (UPEC) are the leading cause of UTI, and antibiotic-resistant UPEC are increasingly common. The microenvironment of the urinary tract is metabolically distinct, and there is growing interest in understanding the extent to which metabolism may influence UPEC infection and response to antibiotics, and how this varies between individuals. Diabetes, characterized in part by glycosuria, is a known risk factor for UTI and is associated with more severe infections. The role that glucose plays in driving UPEC evolution remains unclear. Through experimental evolution with a single UPEC isolate, we identified mutations in the RNA polymerase sigma factor rpoS associated with long-term glucose exposure. We found that the presence of the antibiotic gentamicin resulted in mutations in genes including trkH , which encodes a potassium ion uptake system previously linked to aminoglycoside resistance, and in the autotransporter hyxB . Strikingly, these mutations were not present in populations exposed to a combination of both glucose and gentamicin. This suggests that glucose may influence the survival of mutants in gentamicin, providing new avenues for understanding the evolution and treatment of UPEC-mediated UTI in high-risk individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, UK.
Förderung
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Choudhary, S., Smith, J. A., McNally, A., & Hall, R. J. (2025). Glucose alters the evolutionary response to gentamicin in uropathogenic Escherichia coli. Microbiology. https://doi.org/10.1099/mic.0.001548
Vancouver
Choudhary S, Smith JA, McNally A, Hall RJ. Glucose alters the evolutionary response to gentamicin in uropathogenic Escherichia coli. Microbiology. 2025. doi:10.1099/mic.0.001548
BibTeX
@article{Choudhary2025,
author = {Choudhary, Shalini and Smith, Jacob A and McNally, Alan and Hall, Rebecca J},
title = {Glucose alters the evolutionary response to gentamicin in uropathogenic Escherichia coli},
journal = {Microbiology},
year = {2025},
doi = {10.1099/mic.0.001548}
}
EUVIMED